Dynamics of the Functional State of Apoptotic, Anti-apoptotic Angiogenesis-Regulating Cytokines (HGF, TNF-α) of the Liver in Children with Chronic Cholecystocholangitis under the Influence of Integrated Treatment with Thiotriazoline and Ascorutin

Authors

  • V.V. Khodan State Higher Educational Institution «Ivano-Frankivsk National Medical University», Ivano-Frankivsk
  • A.B. Volosyanko State Higher Educational Institution «Ivano-Frankivsk National Medical University», Ivano-Frankivsk

DOI:

https://doi.org/10.22141/2224-0551.6.49.2013.84842

Keywords:

hepatocyte growth factor, children, state of the liver, chronic cholecystocholangitis, treatment

Abstract

The study included 120 children with chronic cholecystocholangitis and associated violation of the functional state of the liver. We have studied indices of hepatocyte growth factor (HGF) and tumor necrosis factor alpha (TNF-α) in the dynamics of the application of complex treatment regimens. There had been detected reduced HGF level in children with chronic cholecystocholangitis who received standard therapy + ascorutin, which is considered as the reduction of regenerative activity of hepatocytes. When used ascorutin and thiotriazoline in combined treatment, significant decrease in HGF level was observed, due to cytoprotective and capillary-stabilizing effects on endotheliocytes of sinusoids and hepatocytes in general. Stabilization of TNF-α probably occurs when thiotriazoline is being used in combined treatment that directly caused by cytoprotective and antioxidant effects of the above preparation.

References

Бибик Е.Ю. Тиотриазолин — потенциальное лекарственное средство с детоксикационной активностью / Е.Ю. Бибик, К.А. Фомина, М.В. Ющак // Український медичний альманах. — 2009. — Т. 12, № 1. — С. 213-217.

Дєльцова О.І. Стовбурові клітини і регенерація печінки / О.І. Дєльцова, С.Б. Геращенко, Г.Б. Кулинич // Науковий вісник Ужгородського університету. — Серія «Медицина». — 2012. — Вип. 1(43). — С. 175-179.

Компанієць К.М. Оцінка впливу еспаліпону на цитокіновий профіль крові у хворих з хронічним некалькульозним холециститом на фоні хелікобактеріозу у сполученні з ішемічною хворобою серця / К.М. Компанієць // Перспективи медицини та біології. — 2011. — Т. III, № 1. — С. 55-58.

Конакова О.В. Ефективність застосування тіотриазоліну для лікування дітей, хворих на гострі вірусні гепатити А та В / О.В. Конакова // Запорожский медицинский журнал. — 2010. — Т. 12, № 5. — С. 37-39.

Мытник З.Н. Тиотриазолин — гордость отечественной медицины и фармации / З.Н. Мытник, Ю.М. Колесник // Запорожский медицинский журнал. — 2010. — Т. 12, № 5. — С. 7-9.

Нальотова О.М. Вплив комбінацій метформіну і тіотриазоліну на ефективність стандартної фармакотерапії у хворих на гіпертонічну хворобу, асоційовану з інсулінорезистентністю / О.М. Нальотова, В.Г. Гур’янов // Експериментальна і клінічна медицина. — 2011. — № 4(53). — С. 80-87.

Поликарпова А.В. Влияние IL-2 на цитокиновый профиль и уровень гормонов в сыворотке крови морских свинок / А.В. Поликарпова, Т.В. Горбач // Вісник Харківського національного університету імені В.Н. Каразіна. — 2009. — Серія «Біологія». — Вип. 9, № 856. — С. 39-43.

Ситник К.О. Взаємозв’язок ФНП-α з обструктивними змінами респіраторної функції легень у хворих на артеріальну гіпертензію з ожирінням / К.О. Ситник, В.І. Смирнова, Д.Ю. Сидоров // Клінічна та експериментальна патологія. — 2011. — Т. Х, № 3(37). — С. 129-132.

Терапевтична ефективність Тіотріазоліну в комплексному лікуванні серцево-судинних захворювань / І.М. Білай, Я.Ю. Різник, С.І. Білай [та ін]. // Актуальні питання фармацевтичної і медичної науки та практики. — 2011. — Т. XXIV, № 1. — С. 47-49.

Трофименко О.М. Стан макрофагальної фагоцитуючої системи у хворих на стеатоз печінки, поєднаний з хронічним некалькульозним холециститом, за наявності синдрому підвищеної стомлюваності / О.М. Трофименко // Сучасна гастроентерологія. — 2010. — № 6(56). — С. 62-67.

Association of IL1A, IL1B, and TNF gene polymorphisms with chronic rhinosinusitis with and without nasal polyposis: A replication study / L. Mfuna Endam, C. Cormier, Y. Bosse [et al.] // Arch. Otolaryngol. Head Neck Surg. — 2010. — Vol. 136(2). — P. 187-192.

Augmenter of liver regeneration may be a candidate for prognosis of HBV related acute on chronic liver failure as a regenerative marker / S. Hongbo, C. Yu, K. Ming [et al.] // Hepatogastroenterology. — 2012. — Vol. 13, № 59. — P. 105-114.

Blake G.J. Novel clinical markers of vascular wall inflammation / G.J. Blake, P.M. Ridker // Circ. Res. — 2001. — Vol. 89. — P. 763-771.

Bradley J.R. TNF-mediater inflammatory disease / J.R. Bradley // J. Pathol. — 2008. — Vol. 214. — P. 291-300.

Elevated serum Hepatocyte Growth Factor in children and young adults with inflammatory bowel disease / Maya Srivastava, David Zurakowski, Peter Cheifetz, Alan Leichtner [et al.] / Journal of Pediatric Gastroenterology & Nutrition. — 2001. — Vol. 33, № 5. — P. 548-553.

Elshtein N. Polymorbidity in gastroenterological practic / N. Elshtein // Acta Medico. — 2006. — № 5. — Р. 70-73.

Freedman S.B. Therapeutic Angiogenesis for coronary artery disease / S.B. Freedman, Jeffrey M. Isner // Ann. Intern. Med. — 2002. — № 132. — Р. 54-71.

Generation of endoderm-derived human induced pluripotent stem cells from primary hepatocytes / H. Liu, Z. Ye, Y. Kim [et al.] // Hepatology. — 2010. — Vol. 51(5). — P. 1810-1819.

Helicobacter pylori and other Helicobacter species in gallbladder and liver of patients with chronic cholecystitis detected by immunological and molecular methods / E. Apostolov, W. Abu-Al-Soud, I. Nilsson [et al.] // Scand. J. Gastroenterol. — 2005. — Vol. 40. — P.96-102.

Hepatocyte growth factor (HGF)/c-Met signaling is required for stem cell mediated liver regeneration / T. Ishikawa, V.M. Factor, J.U. Marquardt [et al.] // Hepatology. — 2011. — Vol. 16, № 1. — P. 247-256.

Hepatocyte growth factor (HGF) and it’s therapeutic applications / Segura-Flores A.A., Gálvez-Gastélum F.J., Alvarez-Rodríguez A. [et al.] // Rev. Gastroenterol. Mex. — 2004. — № 69. — P. 243-250.

Hepatocyte growth factor: Molecular biomarker and player in cardioprotection and cardiovascularregeneration / R. Madonna, C. Cevik, M. Nasser [et al.] // Thromb. Haemost. — 2012. — № 8. — P. 107-116.

Induction of HGF and VEGF in hepatic regeneration after hepatotoxin-induced cirrhosis in mice / N. Tekkesin, Y. Taga, A. Sav [et al.] // Hepatogastroenterology. — 2011. — № 58 — P. 971-979.

Inhibition of hepcidin transcription by growth factors / J.B. Goodnough, E. Ramos, E. Nemeth [et al.] // Hepatology. — 2012. — Vol. 25, № 10. — P. 1002-1015.

Insulin sensitivity: Gender-related differences in subjects with normal glucose tolerance / G.P. Carnevale Schianca, L. Castello, R. Rapetti [et al.] // Nutrition, Metabolism and Cardiovascular Diseases. — 2006. — Vol. 16, № 5. — P. 339-344.

Jeffrey D. Molecular mediators of hepatic steatosis and liver injury / D. Jeffrey, J. Browning, D. Horton // Clin. Invest. — 2004. — Vol. 114, № 2. — P. 147-152.

Jiang W.G. Hepatocyte growth factor/scatter factor, a cytokine playing multiple and converse roles / Jiang W.G., Hiscox S. // Histol. Histopathol. — 1997. — № 12. — P. 537-555.

Met, metastasis, motility and more / Carmen Birchmeier, Walter Birchmeier, Ermanno Gherardi [et al.] // Nature Reviews Molecular Cell. Biology. — 2003. — № 4. — P. 915-925.

Moseley R.H. Liver and biliary tracts / R.H. Moseley // Curr. Opin. Gastroenterol. — 2003. — Vol. 19. — P. 185-193.

Regulation of microRNA expression by hepatocyte growth factor in human head and neck squamous cell carcinoma / D. Susuki, S. Kimura, S. Naganuma [et al.] // Cancer Sci. — 2011. — № 8. — P. 1349-1356.

Downloads

Published

2013-10-01

Issue

No. 6.49 (2013)

Section

Clinical Pediatrics

License

Copyright (c) 2013 V.V. Khodan, A.B. Volosyanko

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Our edition uses the copyright terms of Creative Commons for open access journals.

Authors, who are published in this journal, agree with the following terms:

  1. The authors retain rights for authorship of their article and grant to the edition the right of first publication of the article on a Creative Commons Attribution 4.0 International License, which allows others to freely distribute the published article, with the obligatory reference to the authors of original works and original publication in this journal.
  2. Directing  the article for the publication to the editorial board (publisher), the author agrees with transmitting of rights for the protection and using the article, including parts of the article, which are protected by the copyrights, such as the author’s photo, pictures, charts, tables, etc., including the reproduction in the media and the Internet; for distributing; for the translation of the manuscript in all languages; for export and import of the publications copies of the writers’ article to spread, bringing to the general information.
  3. The rights mentioned above authors transfer to the edition (publisher) for the unlimited period of validity and on the territory of all countries of the world.
  4. The authors guarantee that they have exclusive rights for using of the article, which they have sent to the edition (publisher). The edition (the publisher) is not responsible for the violation of given guarantees by the authors to the third parties.
  5. The authors have the right to conclude separate supplement agreements that relate to non-exclusive distribution of their article in the form in which it had been published in the journal (for example, to upload the work to the online storage of the journal or publish it as part of a monograph), provided that the reference to the first publication of the work in this journal is included.
  6. The policy of the journal permits and encourages the publication of the article in the Internet (in institutional repository or on a personal website) by the authors, because it contributes to productive scientific discussion and a positive effect on efficiency and dynamics of the citation of the article.
  7. The rights to the article are deemed transferred by the authors to the edition (the publisher) since the moment of the publication of the article in the printed or electronic version of journal.